Intramers and Aptamers: Applications in Protein‐Function Analyses and Potential for Drug Screening
暂无分享,去创建一个
[1] E. Luzi,et al. Designing ribozymes for the inhibition of gene expression. , 1998, Trends in biotechnology.
[2] D. Bartel,et al. Selective optimization of the Rev-binding element of HIV-1. , 1993, Nucleic acids research.
[3] M. Nóbrega,et al. Comparative genomics at the vertebrate extremes , 2004, Nature Reviews Genetics.
[4] H. U. Göringer,et al. In vitro selection of high-affinity nucleic acid ligands to parasite target molecules. , 2003, International journal for parasitology.
[5] A. Ellington,et al. Polyvalent Rev Decoys Act as Artificial Rev-Responsive Elements , 1999, Journal of Virology.
[6] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[7] M. Famulok,et al. IN-VITRO-SELEKTION SPEZIFISCH LIGANDENBINDENDER NUCLEINSAUREN , 1992 .
[8] M. Famulok,et al. Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Michael T. McManus,et al. Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.
[10] U. Schepers,et al. RNA interference: from an ancient mechanism to a state of the art therapeutic application? , 2003, Naturwissenschaften.
[11] L. Cassiday,et al. Yeast genetic selections to optimize RNA decoys for transcription factor NF-κB , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. H. Burke,et al. Expressing RNA aptamers inside cells to reveal proteome and ribonome function. , 2002, Briefings in functional genomics & proteomics.
[13] L. Cassiday,et al. In vivo recognition of an RNA aptamer by its transcription factor target. , 2001, Biochemistry.
[14] J C Cox,et al. Automated selection of anti-protein aptamers. , 2001, Bioorganic & medicinal chemistry.
[15] Nebojsa Janjic,et al. Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.
[16] T. Tuschl,et al. RNA Interference and Small Interfering RNAs , 2001, Chembiochem : a European journal of chemical biology.
[17] J. Claverie,et al. What If There Are Only 30,000 Human Genes? , 2001, Science.
[18] Razvan Nutiu,et al. Signaling Aptamers for Monitoring Enzymatic Activity and for Inhibitor Screening , 2004, Chembiochem : a European journal of chemical biology.
[19] Amy C Yan,et al. Protein-dependent ribozymes report molecular interactions in real time , 2002, Nature Biotechnology.
[20] A. Hüttenhofer,et al. In vitro and in vivo characterization of novel mRNA motifs that bind special elongation factor SelB. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Cairns,et al. Catalytic DNA: a novel tool for gene suppression. , 2002, Current drug targets.
[22] Phillip A. Sharp,et al. The RNAi revolution , 2004, Nature.
[23] R. Jenison,et al. High-throughput ribozyme-based assays for detection of viral nucleic acids. , 2004, Chemistry & biology.
[24] R. Treisman,et al. The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.
[25] B. Stockwell. Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.
[26] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[27] J. KlugS,et al. 特異な延長因子SelBに結合する新規mRNAモチーフのin vitro及びin vivoにおける性質 , 1997 .
[28] Michael Famulok,et al. All you wanted to know about SELEX , 2004, Molecular Biology Reports.
[29] G. Hannon. RNA interference : RNA , 2002 .
[30] R. Strausberg,et al. From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes , 2003, Science.
[31] M. Famulok,et al. Sensing complex regulatory networks by conformationally controlled hairpin ribozymes. , 2004, Nucleic acids research.
[32] M Yarus,et al. Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.
[33] A. Branch,et al. A good antisense molecule is hard to find , 1998 .
[34] Andrew Ellington,et al. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons , 1999, Nature Biotechnology.
[35] D. H. Burke,et al. Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli. , 2003, RNA.
[36] T. Böhm,et al. Controlling small guanine–nucleotide-exchange factor function through cytoplasmic RNA intramers , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Famulok,et al. Oligonucleotide aptamers that recognize small molecules. , 1999, Current opinion in structural biology.
[38] External Regulation of Hairpin Ribozyme Activity by an Oligonucleotide Effector , 2003, Chembiochem : a European journal of chemical biology.
[39] Herbert Waldmann,et al. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. , 2002, Angewandte Chemie.
[40] Herbert Waldmann,et al. From protein domains to drug candidates – natural products as guiding principles in , 2002 .
[41] Timothy J Mitchison,et al. Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. , 2002, Chemistry & biology.
[42] B. Seed,et al. αLβ2 Integrin/LFA-1 Binding to ICAM-1 Induced by Cytohesin-1, a Cytoplasmic Regulatory Molecule , 1996, Cell.
[44] Jeff Zimmerman,et al. Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] Michael Famulok,et al. Reporter ribozymes for real-time analysis of domain-specific interactions in biomolecules: HIV-1 reverse transcriptase and the primer-template complex. , 2002, Angewandte Chemie.
[46] A. Ellington,et al. Aptamers as potential nucleic acid pharmaceuticals. , 1995, Biotechnology annual review.
[47] R. Plasterk,et al. Dicers at RISC The Mechanism of RNAi , 2004, Cell.
[48] M. Famulok,et al. Nucleic acid aptamers-from selection in vitro to applications in vivo. , 2000, Accounts of chemical research.
[49] G. Ferbeyre,et al. Expressing active ribozymes in cells. , 2000, Current issues in molecular biology.
[50] Georg Sczakiel,et al. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. , 2002, Nucleic acids research.
[51] B. Polisky,et al. Zeptomole detection of a viral nucleic acid using a target-activated ribozyme. , 2003, RNA.
[52] Michael Famulok,et al. In Vitro Selection of Specific Ligand‐binding Nucleic Acids , 1992 .
[53] John J Rossi,et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase , 2004, Nature Biotechnology.
[54] M. Kurz,et al. ADP-specific sensors enable universal assay of protein kinase activity. , 2004, Chemistry & biology.
[55] G. F. Joyce,et al. In vitro evolution of nucleic acids. , 1994, Current opinion in structural biology.
[56] H. Steinhoff,et al. HIV-1 Reverse Transcriptase-Pseudoknot RNA Aptamer Interaction Has a Binding Affinity in the Low Picomolar Range Coupled with High Specificity* , 2000, The Journal of Biological Chemistry.
[57] M. Gerstein,et al. A question of size: the eukaryotic proteome and the problems in defining it. , 2002, Nucleic acids research.
[58] J. Casanova,et al. GTPase Signaling: Bridging the GAP between ARF and Rho , 2002, Current Biology.
[59] H. Waldmann,et al. Von Proteindomänen zu Wirkstoffkandidaten - Naturstoffe als Leitstrukturen für das Design und die Synthese von Substanzbibliotheken , 2002 .
[60] M. Famulok,et al. Intramers as promising new tools in functional proteomics. , 2001, Chemistry & biology.
[61] G. Powis,et al. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin , 2004, Cancer Chemotherapy and Pharmacology.
[62] M. Famulok,et al. Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[63] Yang Li,et al. Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. , 2002, Antisense & nucleic acid drug development.
[64] R. Cedergren,et al. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribosome Escherichia colimutant , 1997, Nature Biotechnology.
[65] J. Wills,et al. Isolation of virus-neutralizing RNAs from a large pool of random sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[66] F. Liu,et al. In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. , 2000, RNA.
[67] J. Rossi. Ribozymes, genomics and therapeutics. , 1999, Chemistry & biology.
[68] J C Cox,et al. Automated RNA Selection , 1998, Biotechnology progress.
[69] Satoshi Nishikawa,et al. Inhibition of HCV NS3 protease by RNA aptamers in cells. , 2003, Nucleic acids research.
[70] Michael Famulok,et al. In vivo-applied functional RNAs as tools in proteomics and genomics research. , 2002, Trends in biotechnology.
[71] Jens Kurreck,et al. Antisense technologies. Improvement through novel chemical modifications. , 2003, European journal of biochemistry.
[72] R. Breaker,et al. Genetic Control by Metabolite‐Binding Riboswitches , 2003, Chembiochem : a European journal of chemical biology.
[73] J. Rossi,et al. Intracellular ribozyme applications. , 2001, Biochemical Society transactions.
[74] L. Gold,et al. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[75] Thomas Tuschl,et al. siRNAs: applications in functional genomics and potential as therapeutics , 2004, Nature Reviews Drug Discovery.
[76] A. Schmidt,et al. Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression. , 1999, Methods in enzymology.
[77] C. Carles,et al. Selective Targeting and Inhibition of Yeast RNA Polymerase II by RNA Aptamers* , 1997, The Journal of Biological Chemistry.
[78] Yingfu Li,et al. Structure-switching signaling aptamers. , 2003, Journal of the American Chemical Society.
[79] Michael Famulok,et al. Sequence-specific detection of MicroRNAs by signal-amplifying ribozymes. , 2004, Journal of the American Chemical Society.
[80] Walter A. Korfmacher,et al. Rapid determination of pharmacokinetic properties of new chemical entities: in vivo approaches. , 2002, Combinatorial chemistry & high throughput screening.
[81] Jörg S. Hartig Dipl.-Chem.,et al. Reporter Ribozymes for Real-Time Analysis of Domain-Specific Interactions in Biomolecules: HIV-1 Reverse Transcriptase and the Primer–Template Complex† , 2002 .
[82] Y. Chen,et al. Intracellular production of DNA enzyme by a novel single-stranded DNA expression vector , 2003, Gene Therapy.
[83] J. Rossi. Controlled, targeted, intracellular expression of ribozymes: progress and problems. , 1995, Trends in biotechnology.
[84] M. Huynen,et al. Prediction of protein function and pathways in the genome era , 2004, Cellular and Molecular Life Sciences CMLS.
[85] J. Rossi,et al. Intracellular applications of ribozymes. , 2001, Methods in enzymology.
[86] D. Patel,et al. Adaptive recognition by nucleic acid aptamers. , 2000, Science.
[87] Sunjoo Jeong,et al. Inhibition of the functions of the nucleocapsid protein of human immunodeficiency virus-1 by an RNA aptamer. , 2004, Biochemical and biophysical research communications.
[88] C. Crews,et al. Chemical genetics: exploring and controlling cellular processes with chemical probes. , 1999, Trends in biochemical sciences.
[89] J. Lis,et al. RNA aptamers as effective protein antagonists in a multicellular organism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[90] F. Ruddle,et al. Impact of transgenic technologies on functional genomics. , 2003, Current issues in molecular biology.